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Hermann Manzke,17 and Stefan Mundlos1,2,14,*
Catel-Manzke syndrome is characterized by Pierre Robin sequence and a unique form of bilateral hyperphalangy causing a clinodactyly
of the index finger. We describe the identification of homozygous and compound heterozygous mutations in TGDS in seven unrelated
individuals with typical Catel-Manzke syndrome by exome sequencing. Six different TGDS mutations were detected: c.892A>G
(p.Asn298Asp), c.270_271del (p.Lys91Asnfs*22), c.298G>T (p.Ala100Ser), c.294T>G (p.Phe98Leu), c.269A>G (p.Glu90Gly), and
c.700T>C (p.Tyr234His), all predicted to be disease causing. By using haplotype reconstruction we showed that the mutation
c.298G>T is probably a founder mutation. Due to the spectrum of the amino acid changes, we suggest that loss of function in TGDS
is the underlying mechanism of Catel-Manzke syndrome. TGDS (dTDP-D-glucose 4,6-dehydrogenase) is a conserved protein belonging
to the SDR family and probably plays a role in nucleotide sugar metabolism.Catel-Manzke syndrome (MIM 302380) is characterized
by Pierre Robin sequence (MIM 261800; HP:0000201)1
and a unique form of bilateral hyperphalangy causing cli-
nodactyly of the index finger (HP:0009467). The condition
was first described by Catel2 in 1961 and Manzke3 in 1966.
Pierre Robin sequence is defined by micrognathia, obstruc-
tion of the airways due to a backward displacement of the
tongue base, and, often but not always, cleft palate.4 The
bilateral clinodactyly is caused by an accessory bone be-
tween the second metacarpal and its corresponding prox-
imal phalanx, resulting in radial deviation of the index
finger.5 This is sometimes referred to as Manzke dysostosis.
Because not all reported cases have a cleft palate, Manzke
suggested replacing the term palatodigital syndrome by
the term micrognathia-digital syndrome.5
Previously, 26 individuals from 24 families with typical
Catel-Manzke syndrome have been reported2,3,6–23 (re-
viewed by Manzke et al.5). Ten cases of an atypical form
of Catel-Manzke syndrome have been described, including
individuals with an extended phenotype20,24–28 and case
subjects with unilateral hyperphalangism.15,29,30 Addi-
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The AmericanRobin sequence have been reported.17,31 In one family
two affected girls and in a second family two affected
boys were observed.12,14 The latter observations and pa-
rental consanguinity in another family20 indicate autoso-
mal-recessive inheritance.
We identified homozygous and compound heterozy-
gous mutations in TGDS in seven unrelated individuals
with typical Catel-Manzke syndrome by using exome
sequencing. Clinical data and mutations are summarized
in Table 1.
Individual 1 is a male infant with healthy, unrelated par-
ents from Cameroon with an unremarkable family history.
He was delivered in the 39th week of pregnancy with a birth
weight of 2,770 g (1.5 SD), length of 45.5 cm (2 SD), and
head circumference of 33 cm (1.6 SD). The diagnosis of
Catel-Manzke syndrome was made at the age of 6 days.
Intubation and ventilation were required due to a Pierre
Robin sequence with severe retrognathia and cleft palate
(Figures 1A and 1B). He had bilateral radial deviation and cli-
nodactyly of the second digit and a mild ulnar deviation of
the third and fourth finger. Radiographs showed the typical
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Table 1. TGDS Mutations and Clinical Presentation of the Seven Analyzed Individuals with Typical Catel-Manzke Syndrome
Individual 1 Individual 2 Individual 35 Individual 45 Individual 52,3,5 Individual 618 Individual 720
Sex male female female female male female female
Consanguinity none none none none none none none
Ethnicity Cameroon British/ South
American
German German German Dutch French
Age at last exam 18 months 3.5 years 16 months 19 years 52 years 17 years 28 years
Mutation
1st mutation c.892A>G
(p.Asn298Asp)
c.298G>T
(p.Ala100Ser)
c.298G>T
(p.Ala100Ser)
c.298G>T
(p.Ala100Ser)
c.298G>T
(p.Ala100Ser)
c.298G>T
(p.Ala100Ser)
c.298G>T
(p.Ala100Ser)
2nd mutation c.270_271del
(p.Lys91Asnfs*22)
c.294T>G
(p.Phe98Leu)
– – – c.700T>C
(p.Tyr234His)
c.269A>G
(p.Glu90Gly)
Type compound
heterozygous
compound
heterozygous
homozygous homozygous homozygous compound
heterozygous
compound
heterozygous
Clinical Manifestations
Pierre Robin
sequence
þ þ þ þ þ þ þ
Cleft palate þ, V-shaped þ, U-shaped þ, U-shaped þ þ, U-shaped high arched
palate, bifid uvula
þ, U-shaped
Manzke
dysostosis
þ þ þ þ þ þ þ
Joint
hypermobility
nr nr nr nr nr þ þ
Congenital
heart defect
– VSD, spontaneous
closure
– – – VSD –
Facial
dysmorphism
(additional to
micrognathia)
low-set ears,
prominent
anthelices
hypertelorism,
upslanted
palpebral fissures,
thin eyebrows
narrow nostrils,
thin arched
eyebrows, full
cheeks,
hypertelorism
mild
hypertelorism,
narrow nose
nr thin eyebrows,
mild proptosis,
long columella,
low-set ears,
dysplastic helices,
small mouth
nr
Other skeletal
anomalies
short toes, short
humeri, short
femora
nr nr clinodactyly V,
genua valga
clinodactyly V,
pectus
deformity
clinodactyly V,
bilateral M.
Perthes
brachymetacarpia,
scoliosis
Other features adducted thumbs,
feet edema, short
neck, wide
fontanelle
nr postnatal
growth
retardation
obstruction of
nasolacrimal
duct
nr bronchial
hyperreactivity in
early childhood
postnatal growth
retardation,
hearing loss
Abbreviations are as follows: nr, not reported; VSD, ventricular septal defect.had a wide anterior fontanelle, low set ears with prominent
anthelices, a short neck, short humeri and femora, adducted
thumbs, edema of the feet and eyelids, and short toes.
Radiographs of humeri, femora, and pelvis were normal.
When last examined at the age of 18 months, he still had
retrognathia and a tracheostomy. However, he had devel-
oped well, was able to walk, and had started speaking. His
height was 77 cm (2.7 SD), his head circumference
48.5 cm (þ0.2 SD), and his weight 10.2 kg (0.3 SD).
Individual 2 is the second child of British and South
American nonconsanguineous parents and has a healthy
older sister. She was delivered at term after an uncompli-
cated pregnancy, with birth weight of 3,534 g (þ0.3 SD)
and head circumference of 35 cm (þ0.25 SD). She was
noted to have a cleft palate, micrognathia, bilateral hand
abnormalities, mild hypertelorism, upslanting palpebral764 The American Journal of Human Genetics 95, 763–770, Decembfissures, and thin eyebrows (Figures 2A–2D and 2F). Echo-
cardiogram revealed a ventricular septal defect (VSD), and
hand radiographs performed at the age of 3 months
showed a triangular-shaped bone inserted between the sec-
ond metacarpal and its proximal phalanx bilaterally
causing radial deviation of the index fingers. On the left
hand an additional pin-shaped ossification center was
visible (Figures 2E and 2G). She underwent cleft palate
repair and jaw distraction procedures. The VSD closed
spontaneously, and her development progressed normally.
When last seen at the age of 3.5 years, her height was
90 cm (2.7 SD), head circumference was 49.3 cm (0.4
SD), and weight was 13.36 kg (þ0.2 SD).
Individuals 3, 4, and 5 correspond to individuals 1, 2, and
3 reported by Manzke and coworkers in 2008 and are
of German descent.5 Individual 5 is the individual firster 4, 2014
Figure 1. Clinical Features of Individuals
1 and 7
(A and B) Clinical photographs of indi-
vidual 1 performed at the age of 6 days
showing severe micrognathia, a short
neck, and low set and dysplastic ears.
(C and D) Hand radiographs of individual 1
at the age of 6 days showing the Manzke
dysostosis.
(E and F) Hand radiographs of individual 7
performed at the age of 28 years showing
bilateral radial deviation and clinodactyly
of the second digit. On the right hand a
triangular-shaped bone is inserted between
the second metacarpal and its proximal
phalanx, and on the left hand the acces-
sory bone and proximal phalanx fused.described byCatel andManzke. NoDNA samples of the par-
ents of individual 3 were available. Individual 4 was last
examined at the age of almost 20 years. She underwent
bilateral osteotomy due to genua valga but is otherwise
healthy. The mother of individual 4 was included in our
study; the father, however, was unavailable for segregation
analysis. Individual 5 has two unaffected children from a
nonconsanguineous marriage who were included in our
study. His unaffected parents were not available for analysis.
Individual 6 is the second child of healthy, unrelated
Dutch parents and is now a 17-year-old adolescent who
was already reported by Kant and coworkers in 1998.18
Growth and development were normal. She now has
thin eyebrows, mild proptosis, low-set ears with dysplastic
helices, a long columella, and a small mouth with high pal-
ate and slightly bifid uvula. She developed Perthes disease
affecting the right hip at the age of 9 years and the left hip
at the age of about 13 years. Her right leg is longer because
of incomplete recovery of the left hip. She has subluxation
of both knees, hypermobile elbow joints, and broad feet.
Her older brother is unaffected.
Individual 7 is a woman who was reported as individual
3 by Nizon and coworkers in 2012 (Figures 1E and 1F).20
She has healthy, unrelated Northern French parents, who
were not available for segregation analysis.
Individuals of family 1 (proband and parents), family 2
(proband and parents), family 4 (proband and mother),
family 5 (proband and children), and the affected individ-
ual of family 7 were subjected to exome sequencing after
approval of the ethical boards of the Charite´, the Chris-
tian-Albrecht-University, and the University of Paris De-
cartes. The probands and/or parents gave their written
consent for genetic testing and publication of images.
High-throughput sequencing and data processing wereThe American Journal of Human Genperformed in NGS-core facilities of
the respective universities or collabo-
rating service providers.
Eight exomes from individuals 2, 4,
5, and their relatives were captured
with SeqCap EZ Human Exome Li-brary version 2.0 kit (Roche NimbleGen). The finished
libraries were sequenced on an Illumina HiSeq 2000
sequencing instrument (Illumina) with a paired-end 2 3
100 bp protocol. On average, this resulted in 6.7 Gb of
mapped unique sequences with a mean coverage of 803,
i.e., 203 coverage for 91% of target sequences and 803
coverage for 85% of target sequences. The CCG VARBANK
pipeline v.2.1 was used for data analysis and filtering with
bwa-aln plus hg19 for mapping of reads in combination
with the GATK toolkit for base quality score recalibration
(BQSR), local realignment, and variant quality score recali-
bration (VQSR). GATK and samtools mpileup were used to
call SNVs and short indels. Software developed in-house
was used to annotate variants on a functional level (see
Web Resources). Four DNA samples, including individual
1, his parents, and individual 7, were subjected to exome
analysis with SureSelect All Exon Kit V2 (Agilent) for tar-
geted enrichment followed by sequencing with Illumina’s
HiSeq system (paired-end 23 100 bp). Sequence reads were
mapped to the haploid human reference genome (hg19)
using Novoalign (Novocraft Technologies). Single-nucleo-
tide variants (SNVs) and short insertions and deletions (in-
dels) were called with GATK toolkit according to the best
practice guidelines and resulted in a high-quality exome
variant set.32–34 The variant annotation on a functional
level was performed with Jannovar and GeneTalk was
used for filtering and further data analysis.35,36
Because a separate analysis of the families did not yield a
single candidate gene, we combined all affected individ-
uals into a case group and selected control subjects that
matched the ethnicity and data quality of the cases for
filtering. We assumed that the prevalence of the disorder
is below 1 in 1,000,000 and has a high penetrance. We
considered a recessive as well as a dominant mode ofetics 95, 763–770, December 4, 2014 765
Figure 2. Clinical Features of Individual 2
(A–C) Clinical photographs of individual 2
performed at the age of 5 months showing
micrognathia, upslanting palpebral fis-
sures, short nose with anteverted nares,
thin eyebrows, and cleft palate.
(D and F) Clinical photographs of both
hands of individual 2 showing the cli-
nodactyly of the index fingers, which is
more pronounced on the left side.
(E and G) Hand radiographs of individual 2
performed at the age of 3 months showing
a triangular-shaped bone inserted between
the second metacarpal and its proximal
phalanx bilaterally causing radial devia-
tion of the index finger. On the left hand
an additional pin-shaped ossification cen-
ter is visible.inheritance. Because none of the families had affected in-
dividuals in more than one generation, we filtered for po-
tential de novo mutations when analyzing the dominant
model of inheritance and could not identify a candidate
gene. For the analysis of a recessive mode of inheritance,
we first filtered the sequence variants in the samples based
on genotype frequency data from large population ge-
netics studies.37,38 We removed sequence variants that
occurred in a homozygous state in more than one individ-
ual of the healthy controls. Alleles that had a heterozygous
state in the affected individuals were removed if their allele
frequency was above 0.01 in healthy controls.
The analysis of the autosomal-recessive model of inheri-
tance yielded three candidate genes:MUC4 (MIM 158372),
MUC6 (MIM 158374), and TGDS. Because mucin genes are
known to be highly variable, we focused on TGDS as the
most likely candidate gene. The following variants in
TGDS (RefSeq accession number NM_014305.2) were iden-
tified: c.892A>G (p.Asn298Asp), c.270_271del (p.Lys91
Asnfs*22), c.298G>T (p.Ala100Ser), c.294T>G (p.Phe98
Leu), and c.269A>G (p.Glu90Gly). We analyzed two addi-
tional individuals with Catel-Manzke syndrome by Sanger
sequencing of all coding exons of TGDS and identified
the homozygous variant c.298G>T in individual 3 and
compound heterozygosity for the variants c.700T>C
(p.Tyr234His); c.298G>T in individual 6. In total, six
different variants (five missense and one nonsense) in
TGDS were detected (Table 1). All candidate mutations
were validated by ABI Sanger sequencing (sequencing
primers are available upon request). Sanger sequencing
demonstrated a biparental mode of inheritance of the
compound heterozygous mutations in the parents except
individual 7 whose parents were not available. We
analyzed seven individuals with Catel-Manzke syndrome
and all of them carried homozygous or compound hetero-
zygous mutations in TGDS.766 The American Journal of Human Genetics 95, 763–770, December 4, 2014The function prediction algorithm
MutationTaster39 classified all vari-
ants as disease causing. SIFT40 pre-
dicted only the amino acid changep.Phe98Leu and p.Tyr234His to be ‘‘tolerated,’’ and
PolyPhen-241 predicted only the amino acid change
p.Phe98Leu to be ‘‘benign.’’ All other alterations were
also predicted to be ‘‘probably damaging’’ or ‘‘damaging.’’
The differences in prediction outputs are most likely due
to different protein sequence alignments.42 The positions
Ala100 and Tyr234 are completely conserved throughout
evolution including E. coli (Figure 3B). The position
Glu90 is conserved in zebrafish, the position Phe98 in
C. elegans, and the position Asn298 in frog (not shown).
Altogether we classify all substitutions to be disease
causing. The amino acid change p.Lys91Asnfs*22 is pre-
dicted to cause nonsense-mediated decay due to the trun-
cation of the protein with the loss of 229 aa residues (out
of a total of 350) at the C terminus.
Except for c.298G>T and c.270_271del, all identified
variants were not previously reported in the databases.
The missense mutation c.298G>T is a known variant,
rs140430952, and was observed in a heterozygous state
in 9 out of 4,300 healthy individuals of European descent
that were analyzed in the National Heart, Lung, and Blood
Institute (NHLBI) Exome Sequencing Project (ESP) and in
40 out of 61,377 individuals that were analyzed by the
Exome Aggregation Consortium (ExAC). The variant
c.270_271del was observed in a heterozygous state in 2
out of 2,132 individuals of African descent in the ESP
data and in 4 out of 61,447 individuals in the ExAC data.
However, both sequence variants, c.298T and c.270_271,
did not occur in a homozygous state in healthy control
subjects, supporting our hypothesis that these alleles are
pathogenic.
If we assume a carrier rate of 0.002 for c.298T in the gen-
eral European population, we would expect a homozygous
individual in 1 out of 1,000,000, which is in good agree-
ment with the estimated prevalence for Catel-Manzke syn-
drome. The relatively high frequency of c.298T in the
AB
C
I-4
Figure 3. Segregation Analysis of the TGDS Variants and Predicted Effects on the Protein
(A) Pedigree structures and TGDS genotypes for the seven families.
(B) Schematic of human TGDS showing the predicted domains, the position of the amino acid changes, and the conservation. RefSeq
accession numbers are as follows: human, NM_014305.2; mouse, NP_083854; zebrafish, AAH_66615; E. coli, WP_001710460; C. elegans,
NP_508390. The predicted domains are based on the Conserved Domain Database. The triangles show conserved positions. The align-
ment was created with BoxShade and ClustalW. The colored background of the aa in the different species indicates the degree of con-
servation (black, conserved; gray, similarity in properties; white, not conserved, no similarity in properties).
(C) Predicted position of the amino acid changes in the structure of TGDS in Pyrococcus horikoshii. The structure of TGDS is shown as a
model created with PyMol. The substrate binding domain is shown in blue, and the NAD binding domain is in light green. The positions
aligning with the amino acid changes in TGDS in our cohort are framed inmagenta. Ala100 and Phe98 are localized in the NAD-binding
domain, and Asn298 is in the substrate binding domain. Glu90 and Tyr234 are localized in two of the loops.European population might be due to a founder effect. We
extracted sequence variants around c.298 from the avail-
able exome data for all affected individuals and estimated
the haplotypes with the statistical software package PHASE
v.2.1.43 Based on ten informative markers, we could recon-The Americanstruct a 50 kb haplotype that is shared by all individuals
with the pathogenic allele c.298T, supporting our hypoth-
esis of a founder mutation (Tables S1–S3 available online).
TGDS (dTDP-D-glucose 4,6-dehydratase/growth-inhi-
biting protein 21) is an evolutionarily conserved 350 aaJournal of Human Genetics 95, 763–770, December 4, 2014 767
protein belonging to the short-chain dehydrogenase/
reductase (SDR) family. It shares a sequence identity of
35% with its E. coli ortholog,44 which catalyzes the synthe-
sis of dTDP-4-oxo-6-deoxy-D-glucose from dTDP-glucose
as part of the rhamnose pathway. Because rhamnose, a
common component of the cell wall and the capsule of
many pathogenic bacteria, does not exist in humans,45
the specific function of TGDS and dTDP-4-oxo-6-deoxy-
D-glucose in humans is unknown.
SDRs are structured as a one-domain Rossman fold that
typically consists of a central beta sheet flanked by three
alpha helices on each side. The beta sheet and the alpha
helices show high conservation, although there are differ-
ences at the loops that are involved in substrate binding.46
According to the NCBI Conserved Domain Database, hu-
man TGDS is predicted to contain an active site, a NADP
binding site, a substrate binding site, and a homodimer
interface (Figure 3B). The amino acid changes p.Ala100Ser
and p.Phe98Leu are located in the NAD binding domain,
the amino acid change p.Asn298Asp is in the substrate
binding site (Figures 3B and 3C), and we presume that
the substitutions impair the functions of the respective do-
mains. The amino acid changes p.Glu90Gly and Tyr234-
His, which are predicted to be located in two of the loops,
possibly change the substrate binding potential of TGDS
(Figure 3C). This could be explained by the loss of the
negatively charged, hydrophilic properties of glutamine
by substitution with the hydrophobic amino acid glycine
and the loss of the aromatic, hydrophobic properties of
tyrosine by substitution with the positively charged, hy-
drophilic amino acid histidine. Because of its proximity,
Tyr243His could also affect the catalytic site.
More than 70 SDR genes exist in humans and have roles
in steroid hormone, prostaglandin, and retinoid metabo-
lisms, as well as extracellular matrix formation.47 The
closest paralog of TGDS in the human genome is UXS1
(UGD; UDP-glucoronate decarboxylase 1), which shares
an identity of 27% at the protein level (UXS1 isoform 1, Re-
fSeq NP_ 001240804 [MIM 609749]). Mice homozygous
for a null allele of UXS1 die prenatally.48 UXS1 encodes a
425 aa enzyme localized in the perinuclear Golgi com-
partment and catalyzes the synthesis of UDP-xylose of
UDP-glucoronate, required in glycosaminoglycan (GAG)
synthesis on proteoglycans. UXS1 does not have any dehy-
dratase activity, emphasizing that UXS1 and TGDS are
probably involved in different enzymatic processes.49
The features of Catel-Manzke syndrome demonstrate
clinical overlap with Desbuquois dysplasia 1 (DBQD1
[MIM 251450]), caused by mutations in CANT150 (MIM
613165), Temtamy brachydactyly syndrome (TPBS [MIM
605282]), caused by mutations in CHSY151 (MIM
601883), and chondrodysplasia with joint dislocations,
GPAPP type (GPAPP deficiency [MIM 614078]), caused by
mutations in IMPAD152 (MIM 614010). Extra ossification
centers distal to the secondmetacarpal50 andmicrognathia
have been described for several individuals with Desbu-
quois dysplasia 1. Hyperphalangism of digits 1–3 is a con-768 The American Journal of Human Genetics 95, 763–770, Decembstant feature of Temtamy brachydactyly syndrome and
some individuals have a cleft palate.53 IMPAD1 mutations
were also identified in two individuals classified as Catel-
Manzke-like with micrognathia and cleft palate, extra ossi-
fication centers, and additional features similar to GPAPP
deficiency.20
Both CANT1 and CHSY1 are involved in proteoglycan
synthesis.54,55 IMPAD1 is involved in proteoglycan sulfa-
tion.52 Based on the clinical overlap to these disorders
and the homology to UXS1, it is plausible that TGDS could
also be involved in either proteoglycan synthesis or sulfa-
tion. Additional features like congenital heart defects, joint
hyperlaxity, pectus deformity, and scoliosis indicate that
alterations in TGDS have a general effect on connective tis-
sue, although milder than alterations in IMPAD1, CANT1,
and CHSY1. Due to the spectrum of the amino acid substi-
tutions, we suggest that loss of function in TGDS is the un-
derlying mechanism of Catel-Manzke syndrome. Because
none of the individuals carries two nonsense mutations,
the missense mutations are probably hypofunctional al-
leles that do not cause complete loss of function.
In summary, we identified homozygous and compound
heterozygous mutations in TGDS as disease causing in a
cohort of individuals with Catel-Manzke syndrome. By us-
ing haplotype reconstruction, we showed that the muta-
tion c.298G>T is probably a founder mutation. Because
of the clinical overlap of Catel-Manzke syndrome with a
spectrum of disorders caused by defects in proteoglycan
synthesis or sulfation, we suppose that TGDS could also
be involved in nucleotide sugar metabolism.Supplemental Data
Supplemental Data include three tables and can be foundwith this
article online at http://dx.doi.org/10.1016/j.ajhg.2014.11.004.Acknowledgments
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Web Resources
The URLs for data presented herein are as follows:
1000 Genomes, http://browser.1000genomes.org
BoxShade Server, http://embnet.vital-it.ch/software/BOX_form.
html
ClustalW Server, http://embnet.vital-it.ch/software/ClustalW.
html
dbSNP, http://www.ncbi.nlm.nih.gov/projects/SNP/
Ensembl Genome Browser, http://www.ensembl.org/index.html
ExAC Browser, http://exac.broadinstitute.org/
GeneTalk, http://www.gene-talk.de/
Human Phenotype Ontology (HPO), http://www.human-
phenotype-ontology.org/
MGI Batch Query, http://www.informatics.jax.org/batch
MutationTaster, http://www.mutationtaster.org/
NCBI Conserved Domains, http://www.ncbi.nlm.nih.gov/
Structure/cdd/wrpsb.cgi
NHLBI Exome Sequencing Project (ESP) Exome Variant Server,
http://evs.gs.washington.edu/EVS/
Online Mendelian Inheritance in Man (OMIM), http://www.
omim.org/
PHASE, http://stephenslab.uchicago.edu/software.html#phase
PolyPhen-2, http://www.genetics.bwh.harvard.edu/pph2/
Protein BLAST, http://www.ncbi.nlm.nih.gov/BLAST/Blast.cgi?
PAGE¼Proteins
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